These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 15051380

  • 1. Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes.
    Renaut L, Colin M, Leite JP, Benko M, D'Halluin JC.
    Virology; 2004 Apr 10; 321(2):189-204. PubMed ID: 15051380
    [Abstract] [Full Text] [Related]

  • 2. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
    Stoff-Khalili MA, Rivera AA, Glasgow JN, Le LP, Stoff A, Everts M, Tsuruta Y, Kawakami Y, Bauerschmitz GJ, Mathis JM, Pereboeva L, Seigal GP, Dall P, Curiel DT.
    Gene Ther; 2005 Dec 10; 12(23):1696-706. PubMed ID: 16034451
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Improved gene delivery to B lymphocytes using a modified adenovirus vector targeting CD21.
    Mailly L, Renaut L, Rogée S, Grellier E, D'Halluin JC, Colin M.
    Mol Ther; 2006 Aug 10; 14(2):293-304. PubMed ID: 16735140
    [Abstract] [Full Text] [Related]

  • 9. Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism.
    Leissner P, Legrand V, Schlesinger Y, Hadji DA, van Raaij M, Cusack S, Pavirani A, Mehtali M.
    Gene Ther; 2001 Jan 10; 8(1):49-57. PubMed ID: 11402301
    [Abstract] [Full Text] [Related]

  • 10. A system for the propagation of adenoviral vectors with genetically modified receptor specificities.
    Douglas JT, Miller CR, Kim M, Dmitriev I, Mikheeva G, Krasnykh V, Curiel DT.
    Nat Biotechnol; 1999 May 10; 17(5):470-5. PubMed ID: 10331807
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors.
    Kühnel F, Schulte B, Wirth T, Woller N, Schäfers S, Zender L, Manns M, Kubicka S.
    J Virol; 2004 Dec 10; 78(24):13743-54. PubMed ID: 15564483
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Generation and selection of targeted adenoviruses embodying optimized vector properties.
    Noureddini SC, Krendelshchikov A, Simonenko V, Hedley SJ, Douglas JT, Curiel DT, Korokhov N.
    Virus Res; 2006 Mar 10; 116(1-2):185-95. PubMed ID: 16293334
    [Abstract] [Full Text] [Related]

  • 19. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
    Kurachi S, Koizumi N, Sakurai F, Kawabata K, Sakurai H, Nakagawa S, Hayakawa T, Mizuguchi H.
    Gene Ther; 2007 Feb 10; 14(3):266-74. PubMed ID: 17006548
    [Abstract] [Full Text] [Related]

  • 20. Genetic targeting of adenovirus vectors using a reovirus sigma1-based attachment protein.
    Schagen FH, Wensveen FM, Carette JE, Dermody TS, Gerritsen WR, van Beusechem VW.
    Mol Ther; 2006 May 10; 13(5):997-1005. PubMed ID: 16515889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.